ERCC2 and glioma: To comprehensively estimate the associations of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma in different ethnic populations, meta-analyses in 10 studies including 3,580 glioma patients and 4,728 controls was carried out.